Dr. Oz Jon Cohen, the executive chairman of Bioreference Laboratories, joins via Zoom, and shares an update on the progress of COVID-19 testing in New York. Plus, he details the specific requirements of drive-thru testing. Click here for original post on Dr. Oz
Search Results for: NEW
Press Release
OPKO Health’s BioReference Laboratories and NYC Health + Hospitals Enter into Laboratory Collaboration to Provide Testing for Coronavirus Disease 2019 (COVID-19)
17
Mar
Mar
OPKO Health’s BioReference Laboratories and NYC Health + Hospitals Enter into Laboratory Collaboration to Provide Testing for Coronavirus Disease 2019 (COVID-19) BioReference Laboratories commits to testing 5,000 New Yorkers each day ELMWOOD PARK, N.J., March 17, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration with the New York City […]
CNBC, Power Lunch Dr. Jon Cohen, BioReference Laboratories Executive Chairman, joins ‘Power Lunch’ to discuss the launch of drive-thru testing and how quickly it will produce results. Click here for original post on CNBC, Power Lunch
genomeweb NEW YORK – Opko’s BioReference Laboratories announced Friday it will provide testing for a drive-through facility for SARS-CoV-2 sample collection in partnership with the New York State Department of Health. The drive-through facility is in New Rochelle, New York, which has been the epicenter of the state’s COVID-19 outbreak. The facility started testing Friday […]
Cuomo said Friday during the opening of a New Rochelle drive-thru facility that will test for Covid-19 Crain’s New York Business New York state could be dealing with virus response for six months or more, Gov. Andrew Cuomo said Friday during the opening of a New Rochelle drive-thru facility that will test for Covid-19. “I don’t believe this is […]
South Florida Business Journal BioReference Laboratories, a subsidiary of Miami-based Opko Health (Nasdaq: OPK), has begun accepting specimen from health care providers throughout the U.S. to test whether or not their patients have COVID-19. The lab launched testing Friday, expecting to start with about 1,000 to 2,000 tests a day. BioReference expects to eventually ramp […]
Press Release
OPKO Health’s BioReference Laboratories Offers Testing for Coronavirus Disease 2019 (COVID-19)
13
Mar
Mar
In partnership with NY State Department of Health, BioReference will provide COVID-19 testing for the first public drive-through testing facility on the East Coast COVID-19 tests now available for use by healthcare providers throughout the US ELMWOOD PARK, N.J., March 13, 2020 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), is now […]
Press Release
OPKO Health’s BioReference Laboratories to Introduce Coronavirus Disease (COVID-19) Test
05
Mar
Mar
COVID-19 test will aid healthcare professionals and public health authorities to identify patients infected with COVID-19 ELMWOOD PARK, N.J., March 05, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced it will offer a test for the novel coronavirus (2019-nCoV), a contagious virus that causes respiratory infection and has shown evidence of human-to-human […]
